Oral direct factor Xa inhibitor gets FDA's OK

被引：3
|
作者：
Thompson, Cheryl A.
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2011年 / 68卷 / 16期
关键词：
D O I：
10.2146/news110054
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：1467 / 1467
页数：1
相关论文
共 50 条
  • [1] Rivaroxaban, an oral direct factor Xa inhibitor
    Piccini, Jonathan P.
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Fox, Keith A. A.
    Califf, Robert M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (06) : 925 - 937
  • [2] Rivaroxaban: An oral direct inhibitor of factor Xa
    Gulseth, Michael P.
    Michaud, Jessica
    Nutescu, Edith A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) : 1520 - 1529
  • [3] Apixaban: an Oral Direct Factor-Xa Inhibitor
    Jimenez, David
    Yusen, Roger D.
    Ramacciotti, Eduardo
    ADVANCES IN THERAPY, 2012, 29 (03) : 187 - 201
  • [4] Apixaban: an Oral Direct Factor-Xa Inhibitor
    David Jiménez
    Roger D. Yusen
    Eduardo Ramacciotti
    Advances in Therapy, 2012, 29 : 187 - 201
  • [5] Evaluation of the oral direct factor Xa inhibitor - betrixaban
    Palladino, Michael
    Merli, Geno
    Thomson, Lynda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (11) : 1465 - 1472
  • [6] Apixaban, an oral, direct inhibitor of activated Factor Xa
    Shantsila, Eduard
    Lip, Gregory Y. H.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (09) : 1020 - 1033
  • [7] Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor
    Abrams, Paris J.
    Emerson, Christopher R.
    PHARMACOTHERAPY, 2009, 29 (02): : 167 - 181
  • [8] Rivaroxaban, the first oral, direct factor Xa inhibitor
    Fassiadis, Nicholas
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (18) : 2945 - 2946
  • [9] An oral anticoagulant with direct Factor-Xa-inhibitor
    Weiche, Iris
    NERVENHEILKUNDE, 2010, 29 (05) : 320 - 320
  • [10] EdoxabanA New Oral Direct Factor Xa Inhibitor
    A. John Camm
    Henri Bounameaux
    Drugs, 2011, 71 : 1503 - 1526
12345